Interim report 2026
Filed with HKEX · Stock code 1681 · · 94 pages · English and Chinese
Corporate Information 2 公司资料 Financial Highlights 5 財務摘要 Management Discussion and Analysis 6 管理層討論及分析 Consolidated Statement of Profit or Loss 24 综合損益表 Consolidated Statement of Profit or Loss and Other Comprehensive Income 25 综合損益及其他全面收益表 Consolidated Statement of Financial Position 26 綜合財務狀況表 Consolidated Statement of Changes in Equity 28 綜合權益變動表 Condensed Consolidated Cash Flow Statement 32 簡明
Consun Pharmaceutical Group Ltd. on 6ix
Earlier from Consun Pharmaceutical
- Next Day Disclosure Return
- Consun Pharmaceutical Group: Clarification announcement in relation to the interim results announcement for the six months ended 30 June 2021
- Consun Pharmaceutical Group: (1) Proposed grant of general mandates to issue new shares and repurchase shares, (2) proposed re-election of directors, (3) proposed final dividend and (4) notice of annual general meeting
- Annual results announcement for the year ended 31 December 2020
- Consun Pharmaceutical Group: Supplemental announcement in relation to the annual report for the year ended 31 December 2019
Later from Consun Pharmaceutical
- Notification Letter to Registered Shareholders and Reply Form
- Notification Letter to Non-Registered Shareholders and Reply Form
- Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2026
Follow Consun Pharmaceutical into a list and get an email when it puts out news.
Follow Consun Pharmaceutical